🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #413

Cancer - Press Review (August 4, 2012) – Revue de presse (4 août 2012)

#413
From: SMW
Date: Sat, 04 Aug 2012 18:29
127 lines
6491 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (August 4, 2012) – Revue de presse (4 août 2012)


Breast Cancer Charity Overstates Value of Mammograms: Researchers‎‎
But, Komen official maintains routine screening gives best chance for
improved survival.
By Amanda Gardner. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/08/03/breast-cancer-charity-overstates-value-of-mammograms-researchers

Cancer debate: Are tumors fueled by stem cells?‎‎‎
How can a cancer come back after it's apparently been eradicated?
Three new studies are bolstering a long-debated idea: that tumors
contain their own pool of stem cells that can multiply and keep
fueling the cancer, seeding regrowth.
By Malcolm Ritter. In BusinessWeek
http://www.businessweek.com/ap/2012-08-01/cancer-debate-are-tumors-fueled-by-stem-cells

FDA Approves Zaltrap For Metastatic Colorectal Cancer‎‎‎
The U.S. Food and Drug Administration Friday approved Zaltrap, a drug
developed by Sanofi SA (SNY, SAN.FR) and Regeneron Pharmaceuticals
Inc. (REGN) to treat advanced colon cancer.
Specifically, the agency approved Zaltrap for use in combination with
a chemotherapy regimen called Folfiri in patients whose cancer has
spread beyond the colon. The approval is also for so-called second
line therapy for use in patients previously treated with an
oxaliplatin-based regimen.
By Jennifer Corbett Dooren. In Wall Street Journal
http://online.wsj.com/article/BT-CO-20120803-710782.html

Depressive symptoms and cancer survival correlated‎‎ ‎‎
Research from The University of Texas MD Anderson Cancer Center has
found that symptoms of depression in patients with newly diagnosed
metastatic kidney cancer are associated with survival and inflammatory
gene regulation may explain this link.
In Science Codex
http://www.sciencecodex.com/ut_md_anderson_study_finds_link_between_depressive_symptoms_and_cancer_survival-96024

Aurka-to-p53 signaling: A link between stem cell regulation and
cancer‎
Findings promote further understanding of the self-renewal mechanism
in embryonic stem cells.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2012-08/tmsh-asa080312.php

Common Skin Cancer a Chronic Condition‎ ‎‎
Risk of new lesions doubles for those with three prior basal cell
carcinomas.
By Barbara Bronson Gray. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/08/02/common-skin-cancer-a-chronic-condition-study-says


Cancer du sein: une organisation accusée de trop vanter la
mammographie‎‎ ‎‎
Des experts médicaux reprochent à une fondation américaine, celle qui
a popularisé le ruban rose, d'exagérer les mérites des mammographies
pour le dépistage du cancer du sein, en omettant d'en évoquer les
inconvénients.
Dans AFP
http://www.google.com/hostednews/afp/article/ALeqM5imQmXTzo19gVL5EcxxCVu5fnuGoQ?docId=CNG.a6c60b7bff4b25fd54cdf3535c59cc4d.531

Cancer du sein : autorisation de l'UE pour un nouveau traitement‎
La société pharmaceutique suisse Novartis vient d'annoncer ce 30
juillet que la Commission européenne lui donnait l'autorisation de
commercialiser son nouveau médicament contre le cancer du sein :
l'Afinitor. Ce feu vert concerne uniquement le traitement des femmes
post-ménopausées atteintes d'un cancer du sein avancé à récepteur
hormonal positif (HR+), en combinaison avec un autre médicament,
l'Exemestane.
Dans MaxiSciences
http://www.maxisciences.com/cancer/cancer-du-sein-autorisation-de-l-039-ue-pour-un-nouveau-traitement_art25970.html

Manger moins salé pour se préserver des cancers de l'estomac
Le Fonds mondial de recherche contre le cancer lance un avertissement
contre la consommation excessive de sel.
Dans Le Point
http://www.lepoint.fr/sante/manger-moins-sale-pour-se-preserver-des-cancers-de-l-estomac-26-07-2012-1489638_40.php

Le cannibalisme cellulaire pour stopper le cancer‎
Des chercheurs marseillais ont découvert des cellules capables de
stopper la croissance du cancer du pancréas.
Par Annie Vergnenegre. Dans France3.fr
http://provence-alpes.france3.fr/info/le-cannibalisme-cellulaire-pour-stopper-le-cancer--75045653.html










Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix-Corman – InTextoResearch – Baelen  (08/2012)
Technical Details
Message-ID: <03bcb7ce-1f95-474a-b7b4-e3c25e9f70a5@k21g2000vbn.googlegroups.com>
Path: arc1-ca.pugleaf.net!g9ni2650791pbo.0!nntp.google.com!border1.nntp.dca.giganews.com!border4.nntp.dca.giganews.com!border2.nntp.dca.giganews.com!nntp.giganews.com!ctu-peer!news.nctu.edu.tw!goblin1!goblin.stu.neva.ru!postnews.google.com!k21g2000vbn.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,6cd281527cbadcdb,start
X-Google-Attributes: gida254ea4a8d,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,UTF8
Received: by 10.66.88.199 with SMTP id bi7mr1702287pab.17.1344319242595;
        Mon, 06 Aug 2012 23:00:42 -0700 (PDT)
Path: arc1-ca.pugleaf.net!g9ni2650791pbo.0!nntp.google.com!border1.nntp.dca.giganews.com!border4.nntp.dca.giganews.com!border2.nntp.dca.giganews.com!nntp.giganews.com!ctu-peer!news.nctu.edu.tw!goblin1!goblin.stu.neva.ru!postnews.google.com!k21g2000vbn.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (August 4, 2012) – Revue de presse (4 août 2012)
Date: Sat, 4 Aug 2012 11:29:29 -0700 (PDT)
Organization: http://groups.google.com
Lines: 127
Message-ID: <03bcb7ce-1f95-474a-b7b4-e3c25e9f70a5@k21g2000vbn.googlegroups.com>
NNTP-Posting-Host: 81.247.104.139
Mime-Version: 1.0
X-Trace: posting.google.com 1344105052 315 127.0.0.1 (4 Aug 2012 18:30:52 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 4 Aug 2012 18:30:52 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: k21g2000vbn.googlegroups.com; posting-host=81.247.104.139; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.1 (KHTML, like
 Gecko) Chrome/21.0.1180.60 Safari/537.1,gzip(gfe)
Bytes: 6130
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable